OOIR: Observatory of International Research

Papers

(The median citation count of Brain Tumor Pathology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation	52
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu	17
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma	16
Preface for Brain Tumor Pathology vol.41 issue 2	16
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas	15
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement	14
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature	14
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis	14
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment	12
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis	11
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma	11
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies	11
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	10
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next	10
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors	9
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym	9
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation	7
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis	6
Preface for Brain Tumor Pathology vol. 39 issue 2	6
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles	6
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report	6
Three-dimensional visualization of human brain tumors using the CUBIC technique	6
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant	5
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment	5
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report	5

Timing of H3K27me3 loss in secondary anaplastic meningiomas	5
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma	5
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas	5
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature	5
Progression of long-term “untreated” oligodendroglioma cases: possible contribution of genomic instability	4
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature	4
A case of primary papillary epithelial tumor of the sella with reverse polarity and paired box 8 expression	4
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment	4
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation	4
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas	4
Aggressive nonfunctioning pituitary neuroendocrine tumors	4
Activated astrocytes drive the accumulation of apolipoprotein E at the brain tumor edge	4
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis	4
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL	3
Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches	3
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology	3
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the T	3
An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive	3
Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature	3
How is rosette formation in brain tumours linked with cerebrospinal fluid spread?	3
Emerging glioneuronal and neuronal tumors: case-based review	3
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature	3
Visualizing the endothelial glycocalyx in human glioma vasculature	3
Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins	2
Analysis of clinical, histological, and genomic information of molecular glioblastoma in a Japanese glioma cohort	2
MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations	2
PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report	2
Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors	2
Liquid biomarkers in glioma	2
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused	2